Changes in COPD mortality rate after amendments to the Preventive Vaccination Law in Japan

European Journal of Public Health

Volumn 23, Issue 1, 2013, Pages 133-139

  Kiyohara, Kosuke ^a   Kojimahara, Noriko ^a   Sato, Yasuto ^a   Yamaguchi, Naohito ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; EVALUATION; FEMALE; HUMAN; INFLUENZA; JAPAN; LEGAL ASPECT; MALE; MIDDLE AGED; MORTALITY; POISSON DISTRIBUTION; REGRESSION ANALYSIS; RISK FACTOR; SEASON; SOCIOECONOMICS; VACCINATION; VERY ELDERLY; VULNERABLE POPULATION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; JAPAN; MALE; MIDDLE AGED; MORTALITY; POISSON DISTRIBUTION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RISK FACTORS; SEASONS; SOCIOECONOMIC FACTORS; VACCINATION; VULNERABLE POPULATIONS;

MLCS; MLOWN;

EID: 84876548343     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckr172     Document Type: Article

References (33)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available at: http://www.goldcopd.com/download.asp?intId=554 (6 August 2010, date last accessed).
2. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1 498-504.
3. Donaldson GC, Wedzicha JA. COPD exacerbations. 1: Epidemiology. Thorax 2006;61:164-8.
4. Rothbarth PH, Kempen BM, Sprenger MJ. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;151:1682-5; discussion 1685-6.
5. Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease. Vaccine 1999;17(Suppl. 1):S91-3.
6. Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331:778-84.
7. Poole PJ, Chacko E, Wood-Baker RW, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2006;25:CD002733.
8. Schembri S, Morant S, Winter JH, MacDonald TM. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax 2009;64:567-72.
9. Wongsurakiat P, Maranetra KN, Wasi C, et al. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004;125:2011-20.
10. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med 1995;152(5 Pt 2): S77-121.
11. BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS. Thorax 1997;52(Suppl. 5):S1-28.
12. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J 1995;8:1398-420.
13. Committee for the Third Edition of the COPD Guidelines of The Japanese Respiratory Society. Guidelines for the Diagnosis and Treatment of COPD. (Chronic Obstructive Pulmonary Disease), 3rd edn. Tokyo, Japan: The Japanese Respiratory Society, 2009.
14. National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004;59(Suppl. 1):1-232.
15. Hirota Y, Kaji M. History of influenza vaccination programs in Japan. Vaccine 2008;26:6451-4.
16. The Ministry of Health, Labour and Welfare. 13th Meeting Examining Demand for Influenza Vaccine. Available at: http://www.mhlw.go.jp/stf/shingi/ 2r9852000000dw7k.html. (6 September 2010, date last accessed).
17. The Ministry of Health, Labour and Welfare. The Monthly Vital Statistics Reports. Available at: http://www.mhlw.go.jp/toukei/saikin/old/k-jinkou.html. (6 August 2010, date last accessed).
18. The Statistics Bureau, Ministry of Internal Affairs and Communications. The Population Estimation. Available at: http://www.stat.go.jp/data/jinsui/index .htm. (6 August 2010, date last accessed).
19. Anthonisen NR, Wright EC, Hodgkin JE. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986;133:14-20.
20. Hansen EF, Phanareth K, Laursen LC, et al. Reversible and irreversible airflow obstruction as predictor of overall mortality in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;159(4 Pt 1):1267-71.
21. Oga T, Nishimura K, Tsukino M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003;167:544-9.
22. Fukuchi Y, Nishimura M, Ichinose M, et al. COPD in Japan: the Nippon COPD epidemiology study. Respirology 2004;9:458-65.
23. Anthonisen NR, Skeans MA, Wise RA, et al. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233-9.
24. Hansell AL, Walk JA, Soriano JB. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003;22:809-14.
25. Camilli AE, Robbins DR, Lebowitz MD. Death certificate reporting of confirmed airways obstructive disease. Am J Epidemiol 1991;133:795-800.
26. Niewoehner DE, Lokhnygina Y, Rice K, et al. Risk indexes for exacerbations and hospitalizations due to COPD. Chest 2007;131:20-8.
27. Burrows B, Knudson RJ, Cline MG, Lebowitz MD. Quantitative relationships between cigarette smoking and ventilatory function. Am Rev Respir Dis 1977;115:195-205.
28. Jindal SK, Aggarwal AN, Chaudhry K, et al. A multicentric study on epidemiology of chronic obstructive pulmonary disease and its relationship with tobacco smoking and environmental tobacco smoke exposure. Indian J Chest Dis Allied Sci 2006;48:23-9.
29. Al-Fayez SF, Salleh M, Ardawi M, Zahran FM. Effects of sheesha and cigarette smoking on pulmonary function of Saudi males and females. Trop Geogr Med 1988;40:115-23.
30. Anthonisen NR, Connett JE, Kiley JP, et al. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272:1497-505.
31. The Ministry of Health, Labor and Welfare, Japan. The National Health and Nutrition Survey in Japan, Japan Health Promotion & Fitness Foundation, 2006. Available at: http://www.health-net.or.jp/tobacco/product/pd100000.html (6 August 2010, date last accessed).
32. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980;93:391-8.
33. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;1:681-6.